Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 63.93
-1.29 (-1.98%)
At close: Jan 23, 2026
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.35 billion as of January 23, 2026. Its market cap has decreased by -50.99% in one year.
Market Cap
1.35B
Enterprise Value
-44.69M
Revenue
1.11B
Ranking
n/a
PE Ratio
7.23
Stock Price
63.93
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.35B, an increase of 16.66%. That is a compound annual growth rate of 0.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.35B | -17.71% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 9.36B |
| Sigachi Industries | 9.06B |
| Ind-Swift Laboratories | 8.67B |
| Valiant Laboratories | 3.13B |
| Nectar Lifesciences | 3.11B |
| Bafna Pharmaceuticals | 2.79B |
| Brooks Laboratories | 1.92B |
| Vaishali Pharma | 1.15B |